检索结果 - Simon Alvis

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

    Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus 由 Sam Illingworth, Ying Di, Maxine Bauzon, Janet Lei-Rossmann, Margaret R. Duffy, Simon Alvis, Brian Champion, André Lieber, Terry Hermiston, Leonard W. Seymour, John Beadle, Kerry D. Fisher

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE) 由 Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey, Ignacio Durán, Luc Dirix, Karen Geboes, Christine Wilkinson-Blanc, G. Pover, Simon Alvis, Brian Champion, Kerry Fisher, Hilary McElwaine-Johnn, John Beadle, Emiliano Calvo

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

    Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection 由 Rocio García‐Carbonero, Ramón Salazar, Ignacio Durán, I. Osmán-García, Luis Paz‐Ares, Juan M. Bozada, Valentina Boni, C Blanc, Leonard W. Seymour, John Beadle, Simon Alvis, Brian Champion, Emiliano Calvo, Kerry D. Fisher

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: